Keywords: eu, label, extension, s-p, remicade, european, commission

EU label extension for S-P's Remicade

Article | 08 January 2007

The European Commission has approved a label extension for US drug major Schering-Plough's Remicade (infliximab) allowing for a shortened infusion ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Schering Plough

Schering-Plough

Go to company listing

Related Drugs

Infliximab

Remicade

Go to drug listing